John B. Wong
Division of Clinical Decision Making
Department of Medicine
Tupper Research Institute
Tufts-New England Medical Center
USA
Name/email consistency: high
- Pharmacogenomics of hepatitis C and decision analysis: a glimpse into the future. Wong, J.B. Hepatology (2002)
- Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis. Wong, J.B., Singh, G., Kavanaugh, A. Am. J. Med. (2002)
- Long-term morbidity, mortality, and economics of rheumatoid arthritis. Wong, J.B., Ramey, D.R., Singh, G. Arthritis Rheum. (2001)
- Estimating future hepatitis C morbidity, mortality, and costs in the United States. Wong, J.B., McQuillan, G.M., McHutchison, J.G., Poynard, T. Am. J. Public. Health (2000)
- Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis. Wong, J.B., Koff, R.S. Ann. Intern. Med. (2000)